0.58 CAD
14.51 B CAD
61.71 B CAD
About Eli Lilly and Company
Sector
Industry
CEO
David A. Ricks
Website
Headquarters
Indianapolis
Founded
1876
ISIN
CA28655A1066
FIGI
BBG01JDLZ5K4
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.
Related stocks
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
XS238628644
Eli Lilly and Company 1.625% 14-SEP-2043Yield to maturity
5.87%
Maturity date
Sep 14, 2043
LLY4099975
Eli Lilly and Company 4.65% 15-JUN-2044Yield to maturity
5.65%
Maturity date
Jun 15, 2044
LLY6153503
Eli Lilly and Company 5.65% 15-OCT-2065Yield to maturity
5.42%
Maturity date
Oct 15, 2065
LLY6003397
Eli Lilly and Company 5.6% 12-FEB-2065Yield to maturity
5.42%
Maturity date
Feb 12, 2065
LLY5750032
Eli Lilly and Company 5.1% 09-FEB-2064Yield to maturity
5.41%
Maturity date
Feb 9, 2064
LLY5871804
Eli Lilly and Company 5.2% 14-AUG-2064Yield to maturity
5.41%
Maturity date
Aug 14, 2064
US532457BU1
Eli Lilly and Company 4.15% 15-MAR-2059Yield to maturity
5.39%
Maturity date
Mar 15, 2059
LLY5547405
Eli Lilly and Company 4.95% 27-FEB-2063Yield to maturity
5.38%
Maturity date
Feb 27, 2063
US532457BY3
Eli Lilly and Company 2.25% 15-MAY-2050Yield to maturity
5.34%
Maturity date
May 15, 2050
LLY4492882
Eli Lilly and Company 3.95% 15-MAY-2047Yield to maturity
5.34%
Maturity date
May 15, 2047
LLY5547404
Eli Lilly and Company 4.875% 27-FEB-2053Yield to maturity
5.33%
Maturity date
Feb 27, 2053
See all LLY bonds
